2024-04-04
Bone mineral density and breast cancer
Oncology
In this study, researchers evaluated the long-term impact (over a total period of 10 years) of breast cancer and its treatment on bone mineral density, particularly after discontinuation of treatment with an aromatase inhibitor. A total of 372 patients with pre- and post-menopausal breast cancer were included in the study. Discontinuation of the aromatase inhibitor at 5 years had a significant impact on bone mineral density. Bone mineral density increased in patients weaned off the aromatase inhibitor during the first 5 years, while a decrease in bone mineral density was observed in patients without aromatase inhibitor weaning.

Last press reviews
Porcine liver and human patient: an unprecedented and functional alliance

#Xenotransplantation #LiverTransplantation #GeneticallyModifiedPigLiver...
Ferroptosis: activating iron to overcome treatment-resistant cancers?

#Ferroptosis #ResistantCancer #LysosomalIron #CD44 #Pancreas #Sarcoma...
Neurodegeneration: the shadow of a deficiency?

#Alzheimer #MS #Parkinson #ALS #VitaminD <br><br><br>